Buy, hold, sell: ANZ, CSL, and Telstra shares

Analysts have given their verdict on these popular blue chip shares.

| More on:
A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ANZ shares are seen as fairly valued now, with positive 2030 strategy developments warranting a hold.
  • Despite CSL's recent share decline due to strategic changes and external pressures, maintaining a hold is advised as it approaches potential resistance levels.
  • Telstra's attractive dividend yield is tempered by growth constraints and market pressures, leading analysts to hold while awaiting infrastructure strategy outcomes.

Are you wanting to add some ASX 200 blue chip shares to your portfolio?

Well, if you are, then let's see what analysts are saying about three of the most popular blue chips on the Australian shares market, courtesy of The Bull. Here's what you need to know about them:

ANZ Group Holdings Ltd (ASX: ANZ)

The team at Sequoia Wealth Management currently rates this big four bank as a hold.

While there have been a lot of positives recently for shareholders, such as the new 2030 strategy, it appears to believe that ANZ's shares have reached fair value. It explains:

The bank recently unveiled its 2030 strategy. The bank announced it would cease the $800 million share buy-back, enabling it to return surplus capital of about $1 billion from its non-operating holding company to the bank. It announced it would integrate Suncorp Bank faster to deliver value. It would accelerate the delivery of the ANZ Plus digital front end to all retail and small business customers. It plans to reduce duplication and simplify the organisation. Investors responded positively to the strategy. The shares have risen from $32.67 on September 24 trade at $37.17 on October 23.

CSL Ltd (ASX: CSL)

Over at MPC Markets, its analysts aren't in a rush to buy this biotech giant's shares despite their heavy decline this year due to disappointing results in August.

However, it certainly isn't suggesting that they sell CSL's shares. Instead, MPC Markets is sitting on the fence with a hold rating. It said:

Shares in this global biotechnology giant were slashed after the company posted full year results on August 19. The company generated revenue and profit growth, but investors reacted negatively to a company restructure that includes a planned demerger of the Seqirus influenza vaccines business amid the United States announcing steep tariffs on imported pharmaceuticals. The shares fell from $271.32 on August 18 to close at $194.23 on September 26.

The shares have partially recovered to trade at $218.14 on October 23. We suggest investors continue holding as we expect it to test a new resistance level of $240. The company is undertaking a $750 million on-market share buy-back in fiscal year 2026.

Telstra Group Ltd (ASX: TLS)

Finally, Bell Potter thinks that telco giant Telstra is a hold.

While the broker finds its dividend yield attractive, it notes that its growth is being constrained and its mobile business is facing price pressure. It said:

The telecommunications giant delivered moderate growth in full year 2025, in our view. However, mobile pricing pressure remains. The company's dividend yield adds appeal, yet growth is constrained by regulatory uncertainty and a saturated domestic market. TLS offers defensive characteristics, but upside is limited until the infrastructure strategy materialises. We retain a hold recommendation on the stock.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

man in old fashioned suit and hat looking through magnifying glass
Blue Chip Shares

Is the CSL share price a generational bargain at $180?

CSL shares are currently trading near a 7-year low.

Read more »

Machinery at a mine site.
Blue Chip Shares

BHP signs US$2 billion deal: Here's the key takeaway

Let’s take a look at what was announced.

Read more »

Business people discussing project on digital tablet.
Blue Chip Shares

Buy, hold, sell: Medibank, Qantas, and Xero shares

Let's see what analysts are saying about these popular blue chip shares.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

Defensive businesses with big yields could be strong choices today…

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Blue Chip Shares

2 big ASX 200 shares this fund manager rates as buys

These large businesses could be strong contenders for returns.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Blue Chip Shares

3 ASX blue-chip shares I'd buy with $3,000 right now

These big stocks have a strong market position. Here’s why they’re buys…

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

3 high-quality ASX 200 shares now trading at multi-year discounts

These shares could be dirt cheap according to analysts.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Blue Chip Shares

Where to invest $10,000 in ASX shares in December

These shares could be great picks for Aussie investors this month.

Read more »